戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 implant placed by this technique without any bone graft.
2 ion of enamel matrix proteins and autogenous bone graft.
3  orthopedic surgery requiring a small-volume bone graft.
4 imally invasive surgical approach to place a bone graft.
5 revious cases of allosensitization following bone graft.
6  is essential for optimal functioning of the bone graft.
7 th a titanium-mesh technique and particulate bone graft.
8 ion following minor surgery with ;low-volume bone graft.
9 s the percentage mineralization of the final bone graft.
10 wever, there is little information regarding bone grafts.
11 limited the clinical use of ionic silver for bone grafts.
12 emineralization can improve consolidation in bone grafts.
13 stem to the extent requiring implantation of bone grafts.
14 s like compressive strength for load-bearing bone grafts.
15 microvascular networks for tissue engineered bone grafts.
16 efects contain skeletal components requiring bone grafting.
17  our quest to find new techniques to enhance bone grafting.
18  engineering is an exciting new technique in bone grafting.
19 T) with and without alveolar corticotomy and bone grafting.
20 nstructed with Le Fort I osteotomy and iliac bone grafting.
21               Case 1 did not need additional bone grafting.
22 ups: (1) unrepaired controls, (2) autologous bone grafts, (3) unseeded Caprotite (a polymer-ceramic c
23 tion properties of enamel matrix proteins to bone grafts after surface coating with either EMD (as a
24 nd treated with SA-PAE/bone graft mixture or bone graft alone.
25 tic rats compared to diabetic rats receiving bone graft alone.
26 ared to the non-antibiotic-loaded barrier or bone graft alone.
27 mal matrix, and nine sites were treated with bone graft alone.
28 ntities normally associated with periodontal bone grafting, although they do support the use of this
29 ay enhance the physical connection between a bone graft and a recipient site.
30 f the contacting surfaces between autologous bone graft and bone bed improved new bone formation and
31 e model to investigate the effect of various bone graft and bone replacement materials on extraction
32 al thoracic or lumbar fusion with autologous bone graft and instrumentation more than 9 months previo
33 hBMP-2 has no proven clinical advantage over bone graft and may be associated with important harms, m
34 ct management (detoxification and mixture of bone graft and tetracycline).
35         These procedures typically include a bone graft and/or membrane therapy.
36                          Advances concerning bone grafting and arthroplasty procedures have resulted
37  and CBVT images were taken prior to initial bone grafting and at the 6-month reentry surgery for 35
38 in this paper include the use of particulate bone grafts and bone graft substitutes, barrier membrane
39 rix material as an alternative to autogenous bone grafts and demineralized cadaver bone to support th
40     Collectively, studies support the use of bone grafts and guided tissue regeneration (GTR) for the
41  defects by guided tissue regeneration using bone grafts and membranes have not always yielded predic
42 generation success may be limited by placing bone grafts and membranes in infected sites.
43 aware of the risk of allosensitization where bone grafts are used.
44                                   Autologous bone grafts are usually well consolidated after 4 to 5 m
45 onv) alveolar decortication and augmentation bone grafting, are matched in this case-control study fo
46                                              Bone grafting as a gold standard of bone repairing is li
47 be utilized as an advantageous interface for bone grafts as they can promote angiogenesis, which impr
48                                              Bone grafting at time of placement was required in 25% o
49  conventional arterial flap (cAF, n = 6) and bone graft (BG, n = 6).
50 e groups: open flap debridement [OFD] alone, bone graft [BG], and bone graft plus a bioabsorbable col
51 n debridement with a bioabsorbable synthetic bone graft, bioabsorbable membrane, and minocycline root
52 lly sized, anatomically shaped, viable human bone grafts can be engineered by using human mesenchymal
53 after the removal of an LPC, GTR, along with bone grafting, can be a very useful tool for its treatme
54 e Fort I osteotomy and interpositional iliac bone grafting could be considered a viable protocol to r
55  found that the addition of PRP to xenogenic bone grafts demonstrated a low regenerative potential in
56 T cells that underwent negative selection on bone graft derived I-E+ cells within the thymus.
57 plications, including drug-delivery systems, bone-graft fillers and medical devices.
58 mplex geometries-to provide patient-specific bone grafts for craniofacial and orthopedic reconstructi
59 seed synthetic and decellularized allogeneic bone grafts for enhancement of scaffold remodeling and f
60 t approval of NMF such as GEM 21S and INFUSE bone grafts for periodontal and oral regenerative therap
61 essfully applied to hESC progenitors to grow bone grafts for use in basic and translational studies.
62 s were performed on unoperated limbs, and in bone grafts from two pigs that had autograft procedures
63   In the larger lesions, EMD plus autogenous bone graft had 3.24 mm new bone height compared to 2.71
64 th other materials without the necessity for bone-graft harvesting or a second procedure to remove th
65                               Traditionally, bone grafts have been used to restore damaged bone.
66 igates the effect of PTH(1-34) on autogenous bone graft healing.
67 ial was to determine whether the addition of bone graft (i.e., demineralized freeze-dried bone allogr
68 in-NGFR+ cells were used to repopulate human bone grafts implanted in severe combined immunodeficient
69  combined therapy has been proposed, using a bone graft in combination with EMD to avoid collapse of
70  with a 1:1 mixture of autologous PRF and HA bone graft in the surgical treatment of mandibular Class
71                  Adults scheduled to receive bone grafting in maxillary, non-molar, single-tooth extr
72   PVR is potentially a reliable indicator of bone graft incorporation and can aid in clinical decisio
73               One of the major challenges in bone grafting is the lack of sufficient bone vasculariza
74 and rehabilitation of atrophic maxillae with bone grafts is a lengthy and demanding procedure.
75 us bone graft, which were simulated by using bone graft material from syngeneic ACTB-eGFP-expressing
76 sults demonstrate that this anorganic bovine bone graft material is able to support the attachment an
77 tudies to 1) examine the interaction of this bone graft material with PDGF-BB and IGF-I and 2) determ
78 n these studies the cells were seeded on the bone graft material, then the material was removed and p
79 decreasing the DBM content per volume of the bone graft material.
80 y enhances the osteogenic properties of this bone graft material.
81                   Porous hydroxyapatite (HA) bone grafting material has a clinically satisfactory res
82                   Porous hydroxyapatite (HA) bone grafting material has been used to fill periodontal
83 ermine the effect that socket filling with a bone grafting material has on the prevention of postextr
84                  Total protein adsorption to bone grafting material was quantified using an enzyme-li
85       Autologous bone is the most successful bone-grafting material; however, limited supply and dono
86                                              Bone graft materials are needed in periodontics that are
87 ta-TCP or CaSO(4) to serve as more effective bone graft materials with enhanced osteogenic properties
88 valuate and compare the healing of different bone grafting materials adjacent to titanium plasma-spra
89 tion of exogenous proteins to the surface of bone grafting materials and the subsequent cellular beha
90                  General trends in synthetic bone grafting materials are shifting towards approaches
91 tion of EMD combined with different types of bone grafting materials in periodontal regenerative proc
92 ity of adsorbed amelogenin to the surface of bone grafting materials when enamel matrix proteins were
93 nt; 2) surgical resection; 3) application of bone grafting materials; and 4) guided bone regeneration
94 nsplantation of bone marrow in the form of a bone graft may facilitate the production of hematopoieti
95  safe prophylactic antimicrobial protocol in bone grafting may enhance osseous volume outcomes.
96 al methods of procuring mandibular symphysis bone grafts may leave soft tissue scarring, and cause pa
97           The most effective option included bone grafts, membranes, and laser treatment (56 euros pe
98  variables was examined including the use of bone grafts, membranes, soft tissue grafts, post-surgica
99 rat mandibular angle and treated with SA-PAE/bone graft mixture or bone graft alone.
100  used in conjunction with pliable atraumatic bone grafting mixture and hydraulic pressure from a surg
101 is to retrospectively evaluate the effect of bone grafting of the defect between the bone crest and t
102 itical hurdle-in vitro cultivation of viable bone grafts of complex geometries-to provide patient-spe
103                                       Within bone grafts of this size and complexity cells were fully
104 ncrease after decortication and augmentation bone grafting offsets the concerns of orthodontic procli
105 latelet-rich plasma (PRP) added to xenogenic bone grafts on bone histomorphometric parameters in a do
106 cally correct regenerate that is better than bone grafting or revascularised free-tissue transfer.
107 vorably with the treatment results utilizing bone grafts or membrane barriers, according to published
108 repair response of bioactive glass synthetic bone graft particles and open debridement in the treatme
109  NBM and DFDBA and adsorb to the interior of bone grafting particles.
110  defects compared with autologous PRF and HA bone graft placed after open-flap debridement (OFD).
111 1.5 mm in Case 2, which required particulate bone graft placement.
112                FDBA and DFDBA had more total bone (grafted plus new) present than E at all time perio
113 ebridement [OFD] alone, bone graft [BG], and bone graft plus a bioabsorbable collagen membrane [BG +
114 l therapeutic modalities, such as autologous bone grafting, present myriad limitations and carry with
115 quelae related to implant placement/advanced bone grafting procedures are a result of injury to surro
116                                              Bone grafting procedures were performed at 194 sites in
117       However, millions of oral and non-oral bone-grafting procedures are performed annually, and onl
118 able role in the detection of posterolateral bone graft pseudarthrosis, especially when hardware is p
119                                              Bone grafting remains the standard treatment for bone de
120 ucidated important aspects of the biology of bone graft remodeling and osteoprogenitor cell different
121 with alveolar decortication and augmentation bone grafting resulted in a significant increase in KT h
122 l combined with autologous PRF and porous HA bone graft results in significant improvements of clinic
123 ID mice implanted with bilateral human fetal bone grafts (SCID-hu mice).
124 f midline were evaluated for the presence of bone graft, solid fusion, clefts, fluid collections, and
125  of enamel matrix derivative plus autogenous bone graft stimulated statistically significant periodon
126 e transmission from a commercially available bone graft substitute (BGS) that is popularly used in cl
127 rphogenetic protein-2 (rhBMP-2) is used as a bone graft substitute in spinal fusion, which unites (fu
128                                Assessment of bone graft substitute incorporation is critical in the c
129     Surgical intervention with PTG used as a bone graft substitute was performed in 10 patients with
130 point for further discoveries of therapeutic bone-graft substitute materials.
131           The review includes an overview of bone graft substitutes and biological adjuncts to bone-r
132 clude the use of particulate bone grafts and bone graft substitutes, barrier membranes for guided bon
133 rently available for clinical application as bone graft substitutes.
134 Synthetic biomaterials are now being used as bone graft substitutes.
135 NLR) were calculated in each patient for the bone graft, the contralateral normal side, and the spine
136 ll remains the undisputed "gold standard" in bone grafting, the realization that bone requirement in
137  with the exception of defect fill following bone grafting, the reduction in variability in clinical
138 e treated with Le Fort I osteotomy and iliac bone grafting to allow for implant-borne prosthetic reha
139 switched abutments; 3) flapless approach; 4) bone grafts to fill the gap between buccal plate and fix
140                                         Nude bone graft transplantation into SCID recipients resulted
141                     Using a murine segmental bone graft transplantation model, we isolated a populati
142                 At defined time points after bone graft transplantation recipients were assayed for c
143 bined blockade of the CD40 and CD28 pathways bone graft transplantation resulted in long-term donor-s
144  In the absence of an immunological barrier, bone graft transplantation resulted in long-term multi-l
145 d with T cells at a physiologic rate by nude bone graft transplantation.
146 sed significantly at 4 and 12weeks in SA-PAE/bone graft-treated diabetic rats compared to diabetic ra
147 ation in normoglycemic rats caused by SA-PAE/bone graft treatment was observed at 4weeks but not at 1
148                                        Large bone grafts used for ridge reconstruction purposes might
149 of the detached cementum in combination with bone grafting using a minimally invasive surgical approa
150 o-stage protocol for generating vascularized bone grafts using mesenchymal stem cells (hMSCs) from hu
151 parison of computed tomographic scans before bone grafting versus 4 to 6 months after bone grafting w
152 ation recipients were assayed for chimerism, bone graft viability, and responses to donor and third p
153 ibodies following orthopedic surgery where a bone graft was deployed intraoperatively.
154 ter ideal osteotomy preparation, particulate bone graft was placed in the osteotomy and appropriately
155 e cyst's removal, a decalcified freeze-dried bone graft was placed to close the defect.
156 ore bone grafting versus 4 to 6 months after bone grafting was performed.
157 lumbar spine fusion, rhBMP-2 and iliac crest bone graft were similar in overall success, fusion, and
158                                              Bone grafts were harvested from the calvarium of rats wi
159                                          The bone grafts were immobilized by a resorbable membrane gl
160                                        Onlay bone grafts were performed on the calvaria of 36 guinea
161 use they reduce the inevitable resorption of bone grafts when used alone.
162 ecrotic defects were treated with autologous bone graft, which were simulated by using bone graft mat
163 esents a promising alternative to autologous bone grafting, which is considered the current gold stan
164 rnover and inflammation after extraction and bone grafting with or without local simvastatin (SIM).
165 in cAF and AVF was significantly superior to bone grafts with a higher bone volume in AVFs (p = 0.01)
166  newly developed calcium metaphosphate (CMP) bone graft, with and without bone-stimulating growth fac
167 one marrow microenvironment in the form of a bone graft would permit stable hematopoietic stem cell e
168 ded that the minimally invasive approach for bone grafting yielded results that were equivalent to mo

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。
 
Page Top